Choice of autogenous conduit for lower extremity vein graft revisions  by Landry, Gregory J. et al.
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Background: Surgical revision to repair stenosis is necessary in about 20% of lower extremity vein grafts (LEVGs).
Alternate conduit, especially arm vein, is often necessary to achieve a policy of all-autogenous revisions. Although basilic
vein harvest necessitates deep exposure in proximity to major nerves, it typically uses a large vein unaffected by prior
intravenous lines and as such appears ideally suited for revisions in which a segmental interposition conduit is needed for
revision within the graft or for extension to a more proximal inflow or distal outflow site. In this report, we describe our
experience with the use of the basilic vein for LEVG revisions compared with other sources of autogenous conduit.
Methods: All patients who underwent LEVG were placed in a duplex scan surveillance program. LEVGs that developed a
focal area of increased velocity or uniformly low velocities throughout the graft with appropriate lesions confirmed with
angiography were candidates for revision. All patients who underwent graft revision with basilic vein segments from
January 1, 1990, to September 1, 2001, were identified, and their courses were reviewed for subsequent adverse events
(further revision or occlusion) and complications of harvest. These revisions were compared with revisions in which
cephalic and saphenous vein were used.
Results: One hundred thirty basilic veins were used to revise 122 LEVGs. The mean follow-up period after revision was
28  27 months. Ninety-three grafts (71%) remained patent with no further revision, and 37 grafts (29%) either needed
additional revisions (22 grafts) or were occluded (15 grafts). Only four of these adverse events (11%) were directly
attributed to the basilic vein segment. Ten of 43 grafts revised with cephalic vein (23%) were either revised or occluded,
of which three were related to the cephalic vein segment (P  not significant, compared with basilic vein). Twenty-four
of 81 grafts revised with saphenous vein (30%) were either revised or occluded, of which 11 were attributed to the
saphenous vein segment (P < .01, compared with basilic vein). Two patients (1.5%) had complications from basilic vein
harvest (one hematoma, one arterial injury). No neurologic injuries resulted from basilic vein harvest.
Conclusion: The basilic vein is a reliable and durable conduit when used to segmentally revise LEVGs. Stenoses rarely
occur within interposed basilic vein segments, and excellent freedom from subsequent revision or occlusion is possible.
We conclude the basilic vein can be safely harvested with minimal complications and is ideally suited for use as a short
segment interposition graft for LEVG revision. (J Vasc Surg 2002;36:238-44.)
The identification of suitable autogenous conduit for
revision of lower extremity vein graft (LEVG) is frequently
challenging. Options include residual ipsilateral or con-
tralateral greater saphenous vein, lesser saphenous vein, or
arm vein, including the cephalic and basilic veins. Because
each of these conduit choices has associated advantages and
disadvantages, a consensus for the ideal conduit has never
been reached. Ideally, conduit should be easily harvested
and of adequate caliber and quality, and the harvest itself
should have a low incidence rate of complications. Perhaps
most importantly, the conduit used for revision should
have a small incidence rate of subsequent need for second-
ary revision or graft occlusion.
Patients who undergo vascular surgical procedures
have frequently undergone saphenous vein removal for
vascular and cardiac procedures. Arm vein harvest is, there-
fore, an essential component of the armamentarium of
vascular surgeons involved in limb salvage surgery and
dedicated to an all-autogenous policy for infrainguinal ar-
terial reconstruction. Although the cephalic vein is typically
more superficial and easily harvested, it is frequently of
small caliber and has often been used for intravenous can-
nulation. The basilic vein, because of its deeper location
and proximity to important nerve and arterial structures, is
rarely used as an intravenous site and is typically a large
caliber vein. Despite its relatively short length, it should be
an ideal conduit for LEVG revisions necessitating short
segments of venous conduit. No available data exist, how-
ever, quantifying the results of vein graft revisions with
basilic vein conduits. The authors’ experience with the
basilic vein for LEVG revisions forms the basis of this
report.
METHODS
All patients who underwent LEVG at either the Ore-
gon Health & Science University or Portland Veteran’s
Administration Medical Center were prospectively entered
into a postoperative duplex ultrasound scan–based vein
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graft surveillance protocol that included history and physi-
cal examination, ankle/brachial index determination, and
duplex scan examination of the entire graft, including the
native inflow and outflow vessels. Patients were evaluated
during their initial hospitalization, every 3 months for the
first year after the initial bypass or revision procedure, and
every 6 months thereafter. All duplex scan examinations
were performed by certified vascular technologists.
The criteria for identification of a graft at risk included
a focal peak systolic velocity (PSV) within the graft or in the
inflow or outflow sites greater than 200 cm/s, a prestenotic
to intrastenotic PSV ratio greater than 3.0, uniformly low
PSV less than 45 cm/s throughout the entire graft, an
interval decrease in the ankle/brachial index greater than
0.2, or a significant change in clinical status. Patients with
duplex scan–detected graft abnormalities underwent arte-
riography before revision.1 Lesions with 50% diameter
stenosis with arteriogram were repaired. The revisions were
performed as soon as possible after the identification of a
suspicious lesion.
Prerevision duplex scan vein mapping was routinely
performed to identify available conduit for revision. Exam-
inations were performed with a 5-MHz to 10-MHz probe,
and vein location was marked on the skin with an indelible
marker. Useable vein length and diameters were recorded.
A vein segment was believed to be potentially useable if no
portion of the vein was less than 2 mm in diameter and
ideally not less than 3 mm in diameter. The basilic vein was
typically mapped from the axilla to the antecubital fossa
unless a dominant branch continued on to the forearm.
The cephalic vein was mapped from the deltopectoral
groove to the antecubital fossa unless a dominant branch
continued on to the forearm. Although most patients had
the veins of both arms mapped, occasionally the mapping
was limited to one arm if sufficient vein for the proposed
procedure was identified. This was done at the discretion of
the vascular laboratory technologists in consultation with
the surgical team.
Basilic vein harvest was performed through a continu-
ous incision at the premarked site. Side branches were
ligated with silk sutures. Veins were prepared with disten-
tion with either chilled autologous blood (60 mL) mixed
with 3000 U heparin, 30 mg papaverine hydrochloride,
and 100 mg lidocaine (Oregon Health & Science Univer-
sity) or with chilled heparinized 0.9% normal saline solu-
tion (Portland Veteran’s Administration Medical Center).
Arm vein harvest sites were closed with running absorbable
sutures in multiple layers. Closed suction drains were not
routinely used. The arms were wrapped with an elastic
compression dressing perioperatively to limit perioperative
ecchymosis and swelling.
Several types of revision procedures were performed
depending on the nature and location of the lesions. Inter-
position vein grafts involved placement of a new vein seg-
ment within a graft and not the proximal or distal anasto-
moses. Proximal revisions and distal extensions involved the
creation of a new anastomosis to the native arterial inflow or
outflow with a new vein segment. Vein patch angioplasty
involved placement of a vein patch over a focal stenosis
rather than placement of a new segment of vein. The type of
revision procedure performed was left to the discretion of
the operating surgeon. Revisions in which a only a vein
patch was placed were excluded because our interest was
primarily in determining the characteristics of segmental
vein grafts with different conduits and it was believed that
the results of a vein patch are less reliant on the source of
vein used.
Patient data were entered into a confidential comput-
erized database (Corel7 Paradox, version 8.0, Borland In-
ternational, Scotts Valley, Calif) and included demographic
data, the date, conduit, inflow and outflow, and indication
for the initial operation, duplex scan surveillance data, and
date, conduit, lesion sites, and procedure performed for
revision procedures. Dates of graft occlusion also were
recorded. The Kaplan-Meier method with log-rank analysis
was used to estimate freedom from subsequent adverse
events after revisions with basilic vein. Adverse events were
defined as either graft occlusion or the need for subsequent
secondary revision. When a revision was necessary or an
occlusion occurred, records were reviewed to determine
whether the adverse event was caused by the interposition
segment that had been placed during the revision or by
remote lesions in either the original graft or in the native
arterial inflow or outflow vessels. These data were com-
pared with the same data obtained from LEVG revised with
cephalic and saphenous vein segments. Statistical analysis
was performed with the 2 test for frequencies and propor-
tions and the t distribution for comparison of means (JMP,
version 3.1.5., SAS Institute, Cary, NC).
RESULTS
Between January 1, 1990, and September 1, 2001, 375
LEVG revisions were performed. Basilic vein was harvested
and used in 149 of these revisions (Table I). In 19 revisions,
the basilic vein was used to perform a vein patch over a focal
stenosis, and these revisions were excluded from further
analysis. In 130 revisions, an interposition segment of
basilic vein was placed either within the graft or from the
graft to a new native inflow or outflow site (50 proximal
revisions, 41 interposition grafts, 39 distal extensions). The
mean length of time between the original operation and the
revision procedure was 21.9  32.2 months (mean 
standard deviation [SD]; median, 8.1 months). The mean
Table I. Revision conduits and types of revisions
performed
Type of revision
Conduit
Basilic Cephalic Saphenous
Vein patch angioplasty 19 6 30
Proximal revision 50 17 35
Interposition 41 8 22
Distal extension 39 22 24
Total 149 53 111
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follow-up period after the revision with basilic vein was
27.5  27.2 months (mean  SD; median, 17.8 months).
During the same time period, 53 LEVG revisions were
performed with a segment of cephalic vein, of which six
were vein patches that were excluded from further analysis.
Forty-seven revisions involved placement of a segment of
cephalic vein (17 proximal revisions, eight interposition
grafts, and 22 distal extensions). The mean length of time
between the original operation and revision was 25.7 
39.3 months (mean  SD; median, 11.0 months). The
mean follow-up period after the revision with cephalic vein
was 26.6  28.4 months (mean  SD; median, 13.0
months). One hundred eleven revisions were performed
with a segment of saphenous vein, of which 30 were vein
patches and excluded from further analysis. Eighty-one
revisions involved placement of a saphenous vein segment
(35 proximal revisions, 22 interposition grafts, and 24
distal extensions). The mean time between the original
operation and revision was 22.8  26.4 months (mean 
SD; median, 12.8 months). The mean follow-up period
after revision was 38.0  31.2 months (mean  SD;
median, 30.1 months; P  .05, compared with basilic and
cephalic vein).
Preoperative duplex scan vein mapping. The results
of duplex scan vein mapping procedures in 296 extremities
were reviewed. Useable basilic vein was identified in 275 of
296 extremities mapped (92.9%). In contrast, a useable
segment of cephalic vein was identified in 224 extremities
(75.7%; P  .001, compared with basilic vein). Maximal
and minimal vein diameters were recorded. Maximal and
minimal basilic vein diameters were 5.7  1.6 mm and
3.3 0.8 mm, respectively. Maximal and minimal cephalic
vein diameters were 4.1  1.2 mm and 2.8  0.8 mm,
respectively (P  .001, compared with basilic vein). The
length of available basilic vein was 23.5  8.1 cm, com-
pared with 32.6  11.6 cm of available cephalic vein (P 
.001).
Freedom from adverse events. Grafts revised with an
interposition segment of basilic, cephalic, and saphenous
vein were evaluated for the occurrence of a subsequent
adverse event (graft occlusion or the need for subsequent
revision). These data are listed in Table II. At 1, 3, and 5
years after revision, 78.1%, 59.0%, and 54.0%, respectively,
of grafts revised with basilic vein were free of a subsequent
adverse event. Of the 130 LEVGs revised with basilic vein,
15 (12%) went on to occlude, 22 (17%) needed subsequent
revisions, and 93 (71%) remained patent without the need
for further revisions.
In 47 LEVGs revised with a cephalic vein segment,
freedom from subsequent adverse events at 1 and 3 years
was 79.0% and 64.1%, respectively (P  not significant
[NS], compared with basilic vein). In 81 LEVGs revised
with a segment of either ipsilateral or contralateral saphe-
nous vein, freedom from adverse events at 1, 3, and 5 years
was 80.4%, 65.0%, and 57.6%, respectively (P  NS, com-
pared with basilic and cephalic vein) (Fig).
Cause of adverse events in revised lower extremity
vein graft (Table III). In the 22 grafts revised with basilic
vein segments that necessitated subsequent revision, nine
(41%) involved a different area in the original graft remote
from the basilic vein segment and seven (32%) involved
progression of native arterial disease in either the inflow or
outflow vessels. Two secondary revisions (9%) were at the
site of an anastomosis between the basilic vein segment and
Table II. Freedom from subsequent adverse events (revision or occlusion) after graft revision
Interval (mo)
Cumulative
freedom
Interval
freedom SE
Adverse
events Withdrawn At risk
Grafts revised with
basilic vein
0-6 0.8483 0.8483 0.0341 17 29 130
6-12 0.7810 0.9327 0.0410 6 14 84
12-24 0.6665 0.8855 0.0515 8 15 64
24-36 0.5896 0.9231 0.0583 4 12 41
36-48 0.5403 0.9507 0.0630 2 6 25
48-60 0.5403 1.0000 0.0630 0 7 17
Graft revised with
cephalic vein
0-6 0.9523 0.9523 0.0332 2 13 47
6-12 0.7901 0.8378 0.0721 5 7 32
12-24 0.7045 0.9144 0.0860 2 4 20
24-36 0.6405 0.9360 0.0992 1 3 14
Grafts revised with
saphenous vein
0-6 0.8648 0.8648 0.0399 10 11 81
6-12 0.8048 0.9400 0.0471 4 6 60
12-24 0.7001 0.8953 0.0573 6 11 50
24-36 0.6204 0.9203 0.0669 3 10 33
36-48 0.6204 1.0000 0.0669 0 5 20
48-60 0.5761 0.9557 0.0754 1 2 15
P  NS with log-rank analysis at all time intervals between grafts revised with basilic, cephalic, and saphenous veins.
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either the native artery or the site of a venovenostomy. In
four secondary revisions (18%), the lesion was within the
previously placed basilic vein segment.
The reason for graft occlusion in the 15 grafts revised
with basilic vein that subsequently occluded was believed to
be causes other than the basilic vein conduit in 11 cases. In
four cases, proximal prosthetic inflow (two aortofemoral
limbs and two femoral-femoral grafts) occlusion coincided
with the LEVG occlusion. In three cases, grafts were to
distal tibial or pedal arteries with poor outflow and no
further distal targets for extension. In four cases, the orig-
inal conduit was noted to be of poor quality and additional
stenoses within the graft not associated with the basilic vein
had been identified. One of these patients refused further
revision, one did not have any further conduit for revision,
one was scheduled for revision but the graft occluded
before revision, and one was followed with subsequent
occlusion.
In four cases in which a graft revised with basilic vein
occluded, the cause for occlusion could not be determined.
In two cases, the patients did not return for follow-up
between the time of revision and the time of occlusion,
which occurred 19 and 27 months after the revisions. In
two cases, the grafts occluded for unknown reasons despite
adequate follow-up.
No occlusions were known to be directly related to
problems with the basilic vein segment. Four secondary
revisions were directly related to problems with the basilic
vein segment. Anastomotic lesions were not included be-
cause the cause of anastomotic lesions may be related to
factors other than the quality of conduit. With exclusion of
the four occlusions of undetermined cause, only four of
126 graft revisions with basilic vein (3.2%) ever had addi-
tional problems related to the basilic vein. In the 37 LEVGs
revised with basilic vein segments that underwent subse-
quent revision or occluded, the basilic vein was identified as
the cause of the problem in four (11%), 29 were caused by
problems in other areas of the graft or native arteries (78%),
and four were from unknown causes (11%).
Ten grafts revised with cephalic vein had adverse events
at 3 years of follow-up (two occlusions, eight revisions).
One occlusion was believed to be caused by poor outflow in
a graft to the dorsalis pedis artery. The cause of the other
occlusion was undetermined. Three of the eight revisions
involved lesions within the cephalic vein conduit, two were
at one of the cephalic vein graft anastomoses, and three
were at other areas in the graft or native vessels. Thus, with
exclusion of the occlusion of undetermined cause, three of
46 cephalic vein segments (6.5%) had subsequent adverse
events (P  NS, compared with basilic vein at 3 years). In
the 10 LEVGs revised with cephalic vein segments that had
subsequent adverse events, three were caused by problems
with the cephalic vein segment (30%), six were caused by
problems in other areas of the graft or native arteries (60%),
and one was of unknown cause (10%; P  NS, in compar-
ison with revisions performed with basilic vein).
Twenty-four grafts revised with a segment of saphe-
nous vein had adverse events at 5 years (two occlusions, 22
revisions). One occlusion was of undetermined nature.
One was caused by poor distal outflow in a graft to the
dorsalis pedis artery. In 22 revisions, 11 were in the saphe-
nous vein segment, three at an anastomosis, five in a differ-
ent portion of the graft, and three in the native arterial
inflow or outflow. Thus, with exclusion of the occlusion of
undetermined cause, 11 of 80 grafts revised with saphenous
vein (13.8%) had subsequent adverse events related to the
saphenous vein (P  .01, compared with basilic vein). In
the 24 grafts with subsequent secondary revisions or occlu-
sions, 11 were believed to be caused by problems with the
saphenous vein segment (46%), 12 were caused by prob-
lems in other areas of the graft or native arteries (50%), and
one was from an unknown cause (4%; P  .005, in com-
parison with grafts revised with basilic vein).
Complications of vein harvest. In 130 basilic vein
harvests, two complications occurred, for a 1.5% complica-
tion rate. One postoperative hematoma necessitated oper-
ative evacuation. One brachial artery injury occurred dur-
ing the harvest and was recognized and repaired. No
neurologic injuries or wound infections occurred as a result
of basilic vein harvest. Two wound hematomas necessitat-
ing surgical drainage resulted after 47 cephalic vein har-
vests, for a 4.3% complication rate. Four complications
occurred after 81 saphenous vein harvests (4.9% complica-
tion rate), including two hematomas, one infection, and
one incisional dehiscence with subcutaneous fat necrosis.
No statistical difference in the rate of harvest complications
was present between the conduits examined.
DISCUSSION
The importance of the use of arm veins in lower ex-
tremity bypass surgery has long been recognized. When the
saphenous vein is not available for bypass procedures, ex-
cellent patency can be achieved with bypasses composed of
either a single segment or spliced arm veins.2-4 With ap-
Table III. Causes of graft occlusion and need for
revision in LEVFs revised with basilic, cephalic, and
saphenous vein
Basilic
(n  130)
Cephalic
(n  47)
Saphenous
(n  81)
Cause of occlusion
Inflow occlusion 4 – –
Previously revised portion
of graft
– – –
New portion of graft or
anastomosis
4 – –
Outflow occlusion 3 1 1
Unknown 4 1 1
Cause for revision
Inflow stenosis 4 1 2
Previously revised portion
of graft
4 3 11
New portion of graft or
anastomosis
11 3 8
Outflow stenosis 3 1 1
Total occlusions or revisions 37 10 24
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proximately 20% of LEVGs ultimately needing operative
revision because of stenoses, the use of alternate vein be-
comes essential to maintain an all-autogenous graft. Al-
though contralateral saphenous vein may be available, it has
frequently been removed for other operative procedures
(eg, coronary bypass or other lower extremity bypass pro-
cedures), with residual segments of both ipsilateral and
contralateral saphenous vein frequently being small or scle-
rotic. In addition, removal of the contralateral saphenous
vein in the presence of contralateral arterial occlusive dis-
ease may be undesirable. The lesser saphenous vein is
occasionally an available option. The lesser saphenous vein,
however, is difficult to harvest with the patient supine, and
harvesting from the prone position typically necessitates
repositioning and reprepping for the subsequent revision
procedure. The authors perform LEVG revision with lesser
saphenous vein infrequently.
The use of arm vein is a critical element of an all-
autogenous revision policy. The cephalic vein is easily har-
vested from its lateral, subcutaneous position. Basilic vein
harvest is less straightforward because of its deeper medial
position in proximity to major nerve and vascular struc-
tures. Both are excellent sources of alternate conduit in
LEVG revisions; however, the basilic vein may have some
modest advantages over cephalic vein when used as a short
segment interposition graft. Because of its easy access, the
cephalic vein is frequently used as a site of intravenous
cannulation. A recent study noted a four-fold increased
incidence rate of venous thrombosis in cephalic veins can-
nulated for peripherally inserted central catheters compared
with basilic veins.5
In this study, the basilic vein was more reliably identi-
fied on preoperative duplex scan vein mapping (93% versus
76%) and was also noted to be larger in diameter. The
optimal conduit diameter is unclear; however, it is likely
that smaller caliber conduits are associated with inferior
patency. In a multivariate analysis, Idu and associates6
found vein diameter less than 3.5 mm to be the only
independent risk factor for the subsequent development of
graft stenosis. The larger caliber of the basilic vein did not
adversely affect patency. Although of theoretic concern,
size mismatch between the basilic vein and other areas of
the graft or the native, particularly tibial, vessels is fre-
quently encountered in composite vein and revised grafts.
We frequently repair focal (1 cm length) stenoses
with a vein patch. These revisions were not included in this
analysis because the source of conduit is less likely to be
important in these cases. With its shorter length compared
with the cephalic vein, the basilic vein appears ideally suited
to revisions in which a short segment of autogenous con-
duit is needed (eg, single stenoses 1 cm in length or
multiple stenoses in close proximity). In most revision
procedures, the length of the basilic vein is adequate for use
as an interposition segment. In these situations, it may be
preferable to save adequately sized cephalic vein for a
situation in which a longer venous segment is necessary.
The cephalic and basilic veins are used increasingly to
create autogenous fistulas for hemodialysis. Although not
directly comparable with the topic of this study, Hakaim,
Nalbandian, and Scott7 did note superior maturation of
transposed basilic vein fistulas (0% nonmaturation) com-
pared with upper arm brachiocephalic fistulas (27% non-
maturation) and wrist radiocephalic fistulas (70% nonmatu-
ration). The 18-month patency rates of upper arm
brachiocephalic fistulas (78%) and transposed basilic vein
fistulas (79%) were equal, with each being markedly better
than that of radiocephalic fistulas (33%). The reason for the
poor performance of the lower arm cephalic vein is unclear.
Ideally, after a LEVG is revised, it would be free of the
need for further revisions and free of the risk of subsequent
occlusion. Clearly, however, these adverse events do occur,
and although excellent assisted primary patency can be
achieved in revised grafts,8-10 no graft is reliably immune
from subsequent problems. In this study, the life-table
incidence rate of subsequent adverse events was equal re-
gardless of the conduit used—basilic, cephalic, or saphe-
nous vein. The incidence rate of either additional revision
or graft occlusion at 1, 2, and 3 years was 78%, 79% and
80%; 67%, 70% and 70%; and 59%, 64%, and 62%, respec-
tively, with the use of basilic, cephalic, and saphenous vein
conduit. These results are not directly comparable because
the choice of conduit was not randomized but rather left to
the discretion of the surgeon.
Despite the fact that these adverse events do occur,
closer examination reveals that they are rarely related to the
basilic vein segment. We have previously shown that when
secondary revisions are necessary, the site of prior revision is
involved in approximately half.8 In this series, only four of
Freedom from occlusion or additional revision after graft revision.
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22 secondary revisions involved the basilic vein conduit. In
cases in which the cause of occlusion could be identified,
none were directly related to the basilic vein, although
admittedly, an element of conjecture is introduced in as-
signing reasons for occlusion. At 5 years of follow-up, only
approximately 3% of basilic vein segments were known to
cause any further adverse events. Cephalic vein interposi-
tion grafts had a 3-year incidence rate of adverse events of
6.5%, and saphenous vein segments had a 5-year incidence
rate of adverse events of approximately 14%. Thus, for all
types of revision conduit, the subsequent patency or need
for revision appears to be determined primarily by the
either the quality of the initial bypass graft conduit or by
progression of disease in the native arterial inflow or out-
flow.
The harvest of basilic vein is associated with surprisingly
few complications. As opposed to leg incisions, which have
a notoriously high complication rate of up to 20%,11 com-
plications of arm vein harvest are rare. Our practice is to
snugly wrap the arm with an elastic bandage after harvest.
Although ecchymosis is common, infection and hematoma
seldom occur. In this series, only one hematoma necessitat-
ing surgical evacuation occurred in 130 basilic vein har-
vests, and no wound infections occurred. The proximity of
the basilic vein to important neurologic and vascular struc-
tures is also a concern. However, only one arterial injury,
which was corrected, and no long-term neurologic injuries
resulted from basilic vein harvest.
That the basilic vein is superior to cephalic vein or other
alternate conduit cannot be definitively concluded from
these data. A randomized trial would be necessary to fur-
ther delineate this. However, it does appear that the basilic
vein is at least comparable with other autogenous conduit
sources. Once used for an LEVG revision, the basilic vein
rarely is the cause of subsequent graft occlusion or the need
for further revision. Despite its less accessible anatomic
location, with meticulous technique, it can be safely har-
vested. Its length and diameter make it ideally suited for
short segment graft interpositions, leaving longer venous
conduits available for other potential uses needing longer
segments of autogenous conduit.
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DISCUSSION
Dr Mark Nehler (Denver, Colo). Dr Landry and colleagues
from Oregon continue their extensive investigation of graft sur-
veillance and operative revision of threatened reversed infraingui-
nal bypass grafts. The present discussion focuses on the use of the
basilic vein for interposition graft revision to treat short-segment
unifocal or multifocal graft/inflow/outflow lesions. As expected
from this group, the results are excellent. Not surprisingly, basilic
veins are larger and shorter than cephalic veins on preoperative
duplex. Rare harvest complications are noted with basilic veins (I
was actually responsible for the lone arterial injury). Assisted pri-
mary patency was 72% at a mean follow-up of over 2 years. Life
table determined freedom from adverse events (occlusion or need
for further revision) was 59% and 54% at 3 and 5 years, which was
no different from cephalic or saphenous interposition graft revi-
sions.
I have a few technical questions. The previous report from
OHSU detailing surgical results in the revision of all threatened
vein grafts demonstrated assisted primary patency rates of 90-plus
percent at 3 and 5 years. Why is the current assisted primary
patency rate with basilic vein interpositions only 72% at a little over
2 years? The very proximal basilic vein can have large diameter
branches that are of relatively short length, making placement of
standard silk ties difficult to avoid narrowing and prevent the tie
from coming off with distension. Do the authors find the need to
suture ligate these branches? Due to the obvious size mismatch
between tibial arteries and the basilic vein interposition graft, how
many times was this situation encountered? Did this necessitate a
longer arteriotomy to match to the vein size and a greater degree of
distal artery exposure and therefore greater incision? As many
patients require assist devices to resume early postoperative ambu-
lation, do the authors have a sense of whether the arm harvest
incisions interfered with patients’ ability to use a walker postoper-
atively? Does the large caliber of the interposition basilic vein
segments change the interpretation of subsequent duplex exami-
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nations with regard to lower velocities? Were unusable basilic vein
segments on duplex determined due to size criteria or lack of
visualization?
Finally, I have several philosophical questions. The authors
have performed and reported extensively on graft surveillance and
graft revision. In addition, the authors have pointed out the
extensive morbidity associated with limb salvage surgery, particu-
larly regarding wound complications. Despite the minimal mor-
bidity associated with arm vein harvest, the morbidity associated
with redo infrainguinal exposures is not minimal. This is impor-
tant, as these are patients with asymptomatic graft lesions fre-
quently nearing the end of life. Do the authors consider these
issues in the management of these patients? For example, would a
patient with persistent postoperative lymphedema and a distal graft
lesion be considered for interventional therapy to avoid a reopera-
tive wound problem accepting an inferior intermediate-term pa-
tency result? Conversely, is a patient who undergoes an operative
revision of a threatened bypass and dies 6 months later with a
patent graft and an operative wound that has yet to heal considered
a success or a failure? Finally, despite the traditional focus on graft
patency and limb salvage, is it really always the best plan to
maximize these two parameters in a population with much lower
intermediate-term survival when doing so frequently has signifi-
cant morbidity? I would like to thank the authors for providing the
manuscript in a timely fashion and the Society for the opportunity
to discuss this important issue.
Dr Gregory J. Landry. Thank you, Dr Nehler, for your
thoughtful discussion. During the time that Mark was in Oregon
he set up the original database to examine revised vein grafts, and
this has been the impetus for much of our subsequent work.
In response to your first question, in this study a different
endpoint was evaluated than in previous studies examining revised
lower-extremity vein grafts. In previous work, we have reported
assisted primary patency of revised lower-extremity vein grafts, and
this is, as you correctly point out, approximately 90% at 5 years,
with the starting point being the date of the original operation. In
the current study, we examined freedom from the need for revision
or occlusion after the initial graft revision, so the starting point is the
date of the original graft revision rather than the original operation,
and this explains why the 5-year assisted patency rate is lower.
The majority of branches arising from the basilic vein can be
ligated with silk ligatures. Great care must be taken to place the
ligatures at least 1 mm away from the basilic vein to prevent
dimpling when the vein is distended. Occasionally the basilic vein
will have broad-based branches which are better managed with a
running polypropylene suture rather than with a silk ligature.
The basilic vein is almost always significantly larger than the
tibial artery. Approximately 20% of graft revisions involve place-
ment of an extension graft to a distal tibial artery. The size
mismatch does not appear to affect patency, and no special mea-
sures are required to manage the size mismatch.
We have been pleasantly surprised by the minimal morbidity
caused by arm vein harvest incisions. It is extremely rare for patients
to complain about their arm incisions compared with the frequent
complaints about leg incision discomfort. The arm incisions do not
appear to interfere with postoperative rehabilitation. The duplex
findings in the basilic vein segments were not examined in this
study. Basilic veins were determined to be unusable if they were not
able to be located or if they were extremely small, typically less than
2 mm in diameter.
The last questions address what is perhaps the most important
current question in lower-extremity bypass surgery, namely, pa-
tient outcomes and quality of life. Clearly there are patients who
meet the criteria for graft revision who have severe comorbidities
or decreased life expectancy in whom graft revision is not in their
best interest. This is clearly a matter of judgment on the part of the
physician as well as communication with the patient, family, and
referring physician and is one of the greatest challenges that we
face. While patency and limb salvage are very tangible outcome
points that we should always seek to maximize, they should not be
at the expense of patient quality of life. This will be particularly
important as vascular surgeons treat an increasingly aging popula-
tion.
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